Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Chromatin activity of IκBα mediates the exit from naïve pluripotency

View ORCID ProfileLuis G. Palma, Daniel Álvarez-Villanueva, María Maqueda, Mercedes Barrero, Arnau Iglesias, Joan Bertran, Damiana Álvarez-Errico, Carlos A. García-Prieto, Cecilia Ballaré, Virginia Rodriguez-Cortez, Clara Bueno, August Vidal, Alberto Villanueva, Pablo Menéndez, Gregoire Stik, View ORCID ProfileLuciano Di Croce, View ORCID ProfileBernhard Payer, View ORCID ProfileManel Esteller, View ORCID ProfileLluís Espinosa, View ORCID ProfileAnna Bigas
doi: https://doi.org/10.1101/2023.07.28.550934
Luis G. Palma
1Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain
2Josep Carreras Leukemia Research Institute, Barcelona Spain
3Centro de Investigación Biomédica en Red Cancer (CIBERONC), Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luis G. Palma
Daniel Álvarez-Villanueva
1Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain
4Institut Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María Maqueda
1Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain
2Josep Carreras Leukemia Research Institute, Barcelona Spain
3Centro de Investigación Biomédica en Red Cancer (CIBERONC), Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mercedes Barrero
5Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnau Iglesias
1Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain
2Josep Carreras Leukemia Research Institute, Barcelona Spain
3Centro de Investigación Biomédica en Red Cancer (CIBERONC), Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joan Bertran
6Faculty of Sciences, Technology and Engineering, Universitat de Vic - Universitat Central de Catalunya, Vic 08500 Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Damiana Álvarez-Errico
2Josep Carreras Leukemia Research Institute, Barcelona Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos A. García-Prieto
2Josep Carreras Leukemia Research Institute, Barcelona Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Ballaré
5Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginia Rodriguez-Cortez
2Josep Carreras Leukemia Research Institute, Barcelona Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clara Bueno
2Josep Carreras Leukemia Research Institute, Barcelona Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
August Vidal
4Institut Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Villanueva
7Catalan Institute of Oncology (ICO/IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Menéndez
2Josep Carreras Leukemia Research Institute, Barcelona Spain
3Centro de Investigación Biomédica en Red Cancer (CIBERONC), Madrid, Spain
8Spanish Network for Advanced Therapies (RICORS-TERAV). Carlos III Health Institute (ISCIII), Spain
9Department of Biomedicine. University of Barcelona, Spain
10Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregoire Stik
2Josep Carreras Leukemia Research Institute, Barcelona Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luciano Di Croce
5Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain
10Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
11Universitat Pompeu Fabra, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luciano Di Croce
Bernhard Payer
5Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain
11Universitat Pompeu Fabra, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bernhard Payer
Manel Esteller
2Josep Carreras Leukemia Research Institute, Barcelona Spain
3Centro de Investigación Biomédica en Red Cancer (CIBERONC), Madrid, Spain
10Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
12Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manel Esteller
Lluís Espinosa
1Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain
3Centro de Investigación Biomédica en Red Cancer (CIBERONC), Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lluís Espinosa
  • For correspondence: [email protected] [email protected]
Anna Bigas
1Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain
2Josep Carreras Leukemia Research Institute, Barcelona Spain
3Centro de Investigación Biomédica en Red Cancer (CIBERONC), Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna Bigas
  • For correspondence: [email protected] [email protected]
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Summary

Maintenance of pluripotency is a multifactorial process in which NF-κB is a negative regulator. Our previous work identified a chromatin role for IκBα, the master regulator of NF-κB signaling, that is critical for the proper regulation of various tissue stem cells. Here, we found that IκBα accumulates specifically in the chromatin fraction of pluripotent embryonic stem cells. IκBα depletion does not affect NF-kB-dependent transcription, but causes a profound epigenetic rewiring in pluripotent stem cells, including alterations in H3K27me3, a histone mark catalyzed by Polycomb repression complex 2. Chromatin changes induced by IκBα depletion affect a subset of pluripotency genes and are associated with altered gene transcription. At the cellular level, IκBα-deficient embryonic stem cells are arrested in a naive pluripotency state when cultured in serum/LIF conditions and fail to exit pluripotency under differentiation conditions. By constructing separation-of-function mutants, we show that the effects of IκBα in regulating stem cell pluripotency are NF-κB-independent, but mainly rely on its chromatin-related function. Taken together, our results reveal a novel mechanism by which IκBα participates in the regulation of the pluripotent state of embryonic stem cells and shed light on the interplay between inflammatory signals and the regulation of pluripotency.

Competing Interest Statement

patent on IkBa SOF mutants

Footnotes

  • Figures are now rearranged and some of the data has been reinterpreted. Some figures are new

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 22, 2024.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Chromatin activity of IκBα mediates the exit from naïve pluripotency
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Chromatin activity of IκBα mediates the exit from naïve pluripotency
Luis G. Palma, Daniel Álvarez-Villanueva, María Maqueda, Mercedes Barrero, Arnau Iglesias, Joan Bertran, Damiana Álvarez-Errico, Carlos A. García-Prieto, Cecilia Ballaré, Virginia Rodriguez-Cortez, Clara Bueno, August Vidal, Alberto Villanueva, Pablo Menéndez, Gregoire Stik, Luciano Di Croce, Bernhard Payer, Manel Esteller, Lluís Espinosa, Anna Bigas
bioRxiv 2023.07.28.550934; doi: https://doi.org/10.1101/2023.07.28.550934
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Chromatin activity of IκBα mediates the exit from naïve pluripotency
Luis G. Palma, Daniel Álvarez-Villanueva, María Maqueda, Mercedes Barrero, Arnau Iglesias, Joan Bertran, Damiana Álvarez-Errico, Carlos A. García-Prieto, Cecilia Ballaré, Virginia Rodriguez-Cortez, Clara Bueno, August Vidal, Alberto Villanueva, Pablo Menéndez, Gregoire Stik, Luciano Di Croce, Bernhard Payer, Manel Esteller, Lluís Espinosa, Anna Bigas
bioRxiv 2023.07.28.550934; doi: https://doi.org/10.1101/2023.07.28.550934

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cell Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (6110)
  • Biochemistry (13888)
  • Bioengineering (10589)
  • Bioinformatics (33663)
  • Biophysics (17347)
  • Cancer Biology (14403)
  • Cell Biology (20392)
  • Clinical Trials (138)
  • Developmental Biology (11003)
  • Ecology (16228)
  • Epidemiology (2067)
  • Evolutionary Biology (20542)
  • Genetics (13528)
  • Genomics (18827)
  • Immunology (13960)
  • Microbiology (32597)
  • Molecular Biology (13556)
  • Neuroscience (71045)
  • Paleontology (533)
  • Pathology (2222)
  • Pharmacology and Toxicology (3785)
  • Physiology (5965)
  • Plant Biology (12175)
  • Scientific Communication and Education (1826)
  • Synthetic Biology (3408)
  • Systems Biology (8247)
  • Zoology (1877)